MedPath

INTERNATIONAL HEALTH ALLIANCE, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

114

PPB:114

Drug Approvals

TOBRIMED EYE DROPS 0.3% W/V

Approval Date
Jul 22, 2024
PPB

OTAGIL 10 TABLETS 10MG

Approval Date
Feb 26, 2024
PPB

OTAGIL 20 TABLETS 20MG

Approval Date
Feb 26, 2024
PPB

VULTIN 400 CAPSULES 400MG

Approval Date
Dec 1, 2023
PPB

NEXON GASTRO-RESISTANT TABLETS 40MG

Approval Date
Dec 1, 2023
PPB

FORVIC 300 TABLETS 300MG

Approval Date
Feb 28, 2023
PPB

ATORVIN 40 TABLETS 40MG

Approval Date
Nov 30, 2022
PPB

ATORVIN 10 TABLETS 10MG

Approval Date
Nov 30, 2022
PPB

ATORVIN 20 TABLETS 20MG

Approval Date
Nov 30, 2022
PPB

LECETAM 500 TABLETS 500MG

Approval Date
Aug 30, 2022
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.